Search clinical trials for: ACE inhibitor ,angiotensin receptor blockers

Total 7782 results

Novartis

Completed

Comparative Study of Valsartan and Amlodipine Versus Amlodipine Alone in Hypertension

Hypertension

Switzerland
University Magna Graecia

Completed

Inhibitors of Angiotensin II in Proteinuric Mesangioproliferative Glomerulonephritis

IGA Glomerulonephritis

Italy
Brigham and Women's Hospital

Active, not recruiting

Prospective Monitoring of Angiotensin Receptor Neprilysin Inhibitor in Older Adults With Heart Failure and Frailty

Frailty | Heart Failure, Systolic

United States
Novartis Pharmaceuticals

Completed

Role of Sacubitril/Valsartan in Improving Provider Performance in Managing Heart Failure Under Medicare Alternative Payment Models

Heart Failure

United States
Cristina Avendaño Solá

Recruiting

Early Treatment With Candesartan vs Placebo in Genetic Carriers of Dilated Cardiomyopathy (EARLY-GENE Trial) (EARLY-GENE)

Cardiomyopathy, Dilated

Spain
Abraham Edgar Gracia-Ramos
National Polytechnic Institute, Mexico

Completed

Telmisartan in Respiratory Failure Due to COVID-19 (STAR-COVID)

COVID-19 | Respiratory Insufficiency | Respiratory Distress Syndrome, Adult | Telmisartan

Mexico
Cairo University

Completed

Telmisartan Versus Enalapril in Heart Failure With Reduced Ejection Fraction Patients With Moderately Impaired Kidney Functions (TRIUMF)

Renal Insufficiency | Heart Failure With Reduced Ejection Fraction

Egypt
Novartis Pharmaceuticals

Completed

Double-dose Valsartan Monotherapy in Hypertension Treatment: an Effectiveness and Safety Evaluation in Chinese Patients.

Hypertension

China
Stanford University
Novartis Pharmaceuticals

Withdrawn

Blood Pressure Lowering in Acute Stroke Trial (BLAST)

Cerebrovascular Accident

United States
University of Erlangen-Nürnberg Medical School

Completed

Telmisartan and Renal Perfusion in Patients With Metabolic Syndrome

Metabolic Syndrome

Germany
Sanofi
Bristol-Myers Squibb

Completed

Irbesartan in Chinese Hypertensive Diabetics With Microalbuminuria

Hypertension

China
Providence Health & Services
AstraZeneca

Completed

Angiotensin II Antagonism of TGF-Beta 1

Hypertension | Diabetic Nephropathy

United States
Kyoto University, Graduate School of Medicine

Completed

Effects of Antihypertensive Drugs in Patients With Hypertension and Obstructive Sleep Apnea (OSA)

Hypertension | Obstructive Sleep Apnea

Japan
Novartis Pharmaceuticals

Completed

Compare the Effect of Aliskiren Plus Valsartan Versus Angiotensin-Converting Enzyme Inhibitor (ACEi) Plus Angiotensin Receptor Blocker (ARB) [Ramipril Plus Telmisartan] on the Renin-Angiotensin-Aldosterone System (RAAS) in Hypertensive Patients

Hypertension

Russian Federation
Technische Universität Dresden

Completed

High Dose Candesartan Versus Quinapril for Restenosis Prophylaxis After Stent Angioplasty

Arterial Occlusive Diseases

Germany
Gachon University Gil Medical Center

Completed

Safety and Effects of Ramipril Combined With Candesartan

Hypertension
Vanderbilt University

Terminated

Contribution of Angiotensin II to Supine Hypertension in Autonomic Failure

Hypertension | Multiple System Atrophy | Pure Autonomic Failure

United States
University of Erlangen-Nürnberg Medical School

Completed

TRENDY Follow-up: Study on Endothelial Function in Subjects With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Germany
Takeda

Completed

Efficacy and Safety Study of Azilsartan Medoxomil Compared to Ramipril for Treating Essential Hypertension

Hypertension

Poland, Germany, Bulgaria, Russian Federation, Serbia, Sweden, Netherlands, Estonia, Slovakia, Finland
Shanghai Municipal Health Bureau

Unknown

Effectiveness Study on Fosinopril and/or Losartan in Patients With Chronic Kidney Disease Stage 3 (FLIP)

Proteinuria | Angiotensin II Type 1 Receptor Blockers | Chronic Kidney Insufficiency | Angiotensin-Converting Enzyme Inhibitors

China
Rong Zhang
National Institute on Aging (NIA); Michigan State University; Texas Health Resources

Recruiting

Impact of Intensive Treatment of SBP on Brain Perfusion, Amyloid, and Tau (IPAT Study) (IPAT)

Hypertension | Subjective Cognitive Decline | Cognitively Normal Older Adults | Family History of Dementia

United States
Hospital Clínico Universitario de Valladolid

Completed

CandeSpartan Study. Candesartan Spanish Response-prediction and Tolerability Study (CandeSpartan)

Migraine | Head Pain

Spain
Brigham and Women's Hospital

Suspended

Preeclampsia: A Marker for Future Cardiovascular Risk in Women

Preeclampsia | Pregnancy Induced Hypertension

United States
Stanford University

Withdrawn

Blood Pressure Lowering in Acute Stroke Trial (BLAST)

Stroke, Acute

United States
Atrial Fibrillation Network
Daiichi Sankyo, Inc.

Completed

Trial to Investigate the Efficacy of Olmesartan in Paroxysmal Atrial Fibrillation

Atrial Fibrillation | Arrhythmia | Heart Disease
Sanofi
Bristol-Myers Squibb

Completed

ARCHIPELAGO: Irbesartan in Patients With Acute Coronary Syndrome Without ST Segment Elevation

Myocardial Ischemia | Hypertension

France, Spain, Italy, Belgium, Canada, Germany, Hungary, United States, Netherlands, United Kingdom, Switzerland
RWTH Aachen University
Bayer; Heidelberg University; CTCA

Terminated

Effect of the Known Antihypertensive Drug Telmisartan on Red Blood Cells and Circulation in the Smallest Blood Vessels (ITEM)

Arterial Hypertension | Diabetes Mellitus Type 2 IRC or NIR

Germany
City Hospitals Sunderland NHS Foundation Trust
Takeda

Unknown

Acute Candesartan Cilexetil Outcomes Stroke Trial (ACCOST)

Cerebrovascular Accident | Acute Stroke

United Kingdom
Connolly, Stuart, M.D.
Bristol-Myers Squibb; Sanofi

Unknown

Irbesartan for the Prevention of Atrial Arrhythmias and Cardiac Electrical Remodeling in Patients With Hypertension and Permanent Pacemakers

Hypertension | Atrial Fibrillation

Canada
Hanlim Pharm. Co., Ltd.

Completed

Study to Evaluate the Safety and PK of LODIENT Tablet 80/2.5mg in Healthy Adult Volunteers

Hypertension

Korea, Republic of
GlaxoSmithKline

Completed

Organized Program To Initiate Lifesaving Treatment In Hospitalized Patients With Heart Failure (OPTIMIZE-HF)

Heart Failure, Congestive
Massachusetts General Hospital

Completed

Effect of Losartan in Patients With Nonobstructive Hypertrophic Cardiomyopathy

Hypertrophic Cardiomyopathy

United States
University of Alabama at Birmingham
University of Colorado, Denver; Translational Research Institute for Metabolism...

Active, not recruiting

ACES - ACE Inhibitors Combined With Exercise for Seniors With Hypertension (ACES)

Hypertension | Sedentary Lifestyle | Aging

United States
St George's, University of London

Terminated

The Renin-Angiotensin System in Essential Hypertension

Hypertension

United Kingdom
Montreal Heart Institute
Novartis Pharmaceuticals

Terminated

ARNI Versus plAcebo in Patients With Congenital sYStemic Right Ventricle Heart Failure (PARACYS-RV)

Heart Failure | Systemic Right Ventricle

Canada
Takeda

Completed

A Study of TAK-536 in Children From 2 to Less Than 6 Years Old With High Blood Pressure

Hypertension

Japan
Palo Alto Veterans Institute for Research
Medtronic; James Cook University, Queensland, Australia

Completed

Study of the Effectiveness of Telmisartan in Slowing the Progression of Abdominal Aortic Aneurysms (TEDY)

Abdominal Aortic Aneurysm

United States
Roxane Laboratories

Completed

Crossover Bioequivalence Study of Irbesartan 300 mg Tablets Under Fed Conditions

Hypertension

United States
Ain Shams University

Completed

Chronopharmacology of Valsartan in Normotensive Subjects

Healthy Normotensive Volunteers

Egypt
Jiangsu HengRui Medicine Co., Ltd.

Completed

The Drug-drug Interaction of SP2086 and Valsartan

Type 2 Diabetes

China
Bristol-Myers Squibb
Sanofi

Completed

Irbesartan in Heart Failure With Preserved Systolic Function (I-Preserve)

Congestive Heart Failure

Netherlands, Portugal, Spain, United States, Belgium, Italy, Argentina, Brazil, Canada, France, Germany, Mexico, South Africa, Sweden, Australia, Russian Federation, Poland, Czech Republic, Denmark, Ireland, Hungary, Switzerland, Gr... and more
Karin Skov
AstraZeneca; University of Aarhus

Unknown

Danish Hypertension Prevention Project - DHYPP

Hypertension

Denmark
Fundación Cardiovascular de Colombia
AstraZeneca

Terminated

Clinical Trial to Assess the Effects of Candesartan on the Carbohydrate Metabolism of Obese Subjects (ARAMIA)

Obesity | Glucose Intolerance

Colombia
Seung-Jung Park
Novartis

Completed

Valsartan for Suppression of Plaque Volume and Restenosis After Drug-Eluting Stent (VAL-SUPPRES)

Coronary Artery Disease

Korea, Republic of
Osaka City University

Completed

Prevention of CHOP-induced Chronic Cardiotoxicity

Non-Hodgkin's Lymphoma

Japan
Sanofi
Bristol-Myers Squibb

Completed

The Efficacy and Safety of Irbesartan 150/12.5 mg and 300/25 mg in Patients With Mild Hypertension

Hypertension

United States
Steno Diabetes Center Copenhagen

Completed

Optimal Dose of Irbesartan for Renoprotection in Type 2 Diabetic Patients With Persistent Microalbuminuria

Type 2 Diabetes | Microalbuminuria

Denmark
Rambam Health Care Campus

Unknown

Non-Insulin Dependent Diabetes Mellitus (NIDDM) and Angiotensin Converting Enzyme 2 (ACE2): Diabetic Patients Treated With Antihypertensive Drugs

NIDDM

Israel
The Japanese Society of Hypertension

Unknown

Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial of Cardiovascular Events in High-Risk Hypertensive Patients

Cardiovascular Diseases | Hypertension

Japan
Chong Kun Dang Pharmaceutical

Not yet recruiting

A Clinical Trial to Evaluate the Blood Pressure Control of Telmisartan or Losartan in Essential Hypertensive Patients With Metabolic Syndrome (PRISTINE)

Metabolic Syndrome | Essential Hypertension

Search clinical trials for: ACE inhibitor ,angiotensin receptor blockers

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uzbekistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations